Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A well differentiated, low grade neuroendocrine tumor (carcinoid tumor) that arises from the ascending colon. The mitotic count is less than 2 per 10 HPF and/or the Ki67 index is equal to or less than 2 percent.
No clinical trials have been registered for ascending colon neuroendocrine tumor G1.
4 publications have been identified in PubMed for ascending colon neuroendocrine tumor G1. Research spans Case Report / Case Series (50%), Other (25%), and Epidemiology / Natural History (25%).
Al-Toubah T (2025). [PMID: 39853885](https://pubmed.ncbi.nlm.nih.gov/39853885/). *Journal of neuroendocrinology*. [Epidemiology / Natural History]
Irizarry SL (2025). [PMID: 40799664](https://pubmed.ncbi.nlm.nih.gov/40799664/). *Cureus*. [Case Report / Case Series]
Long A (2025). [PMID: 41094574](https://pubmed.ncbi.nlm.nih.gov/41094574/). *Diagnostic pathology*. [Other]
Ahuja S (2024). [PMID: 39121720](https://pubmed.ncbi.nlm.nih.gov/39121720/). *International journal of surgery case reports*. [Case Report / Case Series]
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 5:39 PM UTC